Following the discovery of IDH-mutations in humans, Choi et al. published a study in 2012 regarding the detection of 2-hydroxyglutarate specifically through MR spectroscopy in patients with gliomas, which accurately correlated with the presence of an IDH-mutation and the diagnosis of WHO-Grade II and III gliomas in adults [14]. This evidence concerns the gene IDH1 and glioma.